Intersect ENT Inc (NASDAQ:XENT)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - XENT
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - XENT
- Market Cap$790.490m
- SymbolNASDAQ:XENT
- IndustryHealthcare
- SectorMedical Devices
- Currency
- ISINUS46071F1030
Company Profile
Intersect ENT Inc are a commercial drug delivery company committed to improving the quality of life for patients with ear, nose and throat conditions. It offer's PROPEL and PROPEL mini drug-releasing implants for patients undergoing sinus surgery to treat chronic sinusitis and PROPEL contour, a steroid-releasing implant to frontal and maxillary sinus ostia or openings of the dependent sinuses. The company generates revenues from the sale of our PROPEL family of products.Intersect ENT Inc is a commercial stage drug-device company engaged in improving the life for patients with ear, nose and throat conditions.
Latest XENT news
Currently there for this company. Visit our news hub for other news .